NEW YORK (GenomeWeb) – Laboratory Corporation of America on Thursday reported a 6 percent growth year over year in fourth quarter revenues, thanks largely to an 8 percent increase in revenues from its diagnostics business.

For the three months ended Dec. 31, 2016, LabCorp posted $2.43 billion in revenues, up from $2.30 billion in Q4 2015 and surpassing the analysts' average estimate of $2.35 billion.

Net revenue in the quarter came in at $2.39 billion, a 6 percent increase from $2.24 billion in Q4 2015, on acquisitions and organic growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.